Oncology
1 drug is in development for Pancreas Cancer.
- Companies
- 1
- Clinical trials
- 19
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Pancreas Cancer pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| NUV-868 | Nuvation Bio Inc. (NUVB) |
About this indication
Pancreas Cancer context
Oncology·MeSH: Pancreatic Neoplasms (D010190)
Narrower concept of MeSH descriptor Pancreatic Neoplasms
Prevalence
7.1 / 100K
Incidence
7.5 / 100K/yr
Frequently asked questions
How many drugs are in development for Pancreas Cancer?
BioSniper tracks 1 drug in development for Pancreas Cancer across 1 company.
How many clinical trials target Pancreas Cancer?
There are 19 clinical trials targeting Pancreas Cancer tracked by BioSniper.
What is the prevalence of Pancreas Cancer?
The estimated prevalence of Pancreas Cancer is approximately 7.1 per 100,000 population.